Pridopidine treatment benefits in definite, probable, and early (<18mo onset) subjects with ALS in the HEALEY ALS Platform Trial

Pridopidine treatment benefits in definite, probable, and early (<18mo onset) subjects with ALS in the HEALEY ALS Platform Trial

Saved in:
Bibliographic Details
Main Authors: Michal Geva, Y Paul Goldberg, Melanie L. Leitner, Kelly Chen, Wei Feng, Noga Gershoni Emek, James D. Berry, Sabrina Paganoni, Jeremy Shefner, Merit ECudkowicz, Michael R. Hayden
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Neurotherapeutics
Online Access:http://www.sciencedirect.com/science/article/pii/S1878747925001539
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items